Apnimed Secures $150 Million Debt Financing and Monetizes SASS Joint Venture Stake

Hogan Lovells has advised HealthCare Royalty Partners. Goodwin has advised Apnimed, Inc. Apnimed, Inc., a pharmaceutical company focused on developing oral therapies for obstructive sleep apnea…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here